yingweiwo

TP-238

Cat No.:V35176 Purity: ≥98%
TP-238 is a potent and specific CECR2/BPTF dual probe with IC50s of 30 nM and 350 nM respectively.
TP-238
TP-238 Chemical Structure CAS No.: 2415263-04-4
Product category: Epigenetic Reader Domain
This product is for research use only, not for human use. We do not sell to patients.
Size Price
500mg
1g
Other Sizes

Other Forms of TP-238:

  • TP-238 hydrochloride
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Product Description
TP-238 is a potent and specific CECR2/BPTF dual probe with IC50s of 30 nM and 350 nM respectively. TP-238 also inhibits BRD9 with pIC50 of 5.9 and is less active against other 338 kinases.
TP-238 (CAS#: 2415263-04-4) is a potent and selective dual probe for the bromodomains of CECR2 and BPTF, with IC50 values of 30 nM and 350 nM, respectively. It has the molecular formula C22H30N4O5S and a molecular weight of 458.58 g/mol. TP-238 also inhibits BRD9 with a pIC50 of 5.9 and shows minimal activity against 338 other kinases. It is a valuable chemical probe for studying the biological roles of CECR2 and BPTF bromodomains in epigenetic regulation. Its high potency and selectivity make it suitable for cellular and in vivo studies.
Biological Activity I Assay Protocols (From Reference)
Targets
CECR2 30 nM (IC50) CECR2 10 nM (Kd) CECR2 7.5 (pIC50) BPTF 350 nM (IC50) BPTF 120 nM (Kd) BPTF 6.5 (pIC50) BRD9 5.9 (pIC50)
The primary biological targets of TP-238 are the bromodomains of CECR2 (cat eye syndrome chromosome region, candidate 2) and BPTF (bromodomain PHD finger transcription factor). Bromodomains are epigenetic reader modules that recognize acetylated lysine residues on histone tails and regulate gene transcription. CECR2 is a component of the CERF (CECR2-containing remodeling factor) chromatin remodeling complex, which is involved in transcriptional regulation. BPTF is a subunit of the NURF (nucleosome remodeling factor) complex. By binding to these bromodomains, TP-238 displaces them from chromatin, thereby modulating gene expression. It also inhibits BRD9 with lower potency.
ln Vitro
TP-238 has metabolic activity that is on target at 10–30 nM for CECR2 and 100–350 nM for BPTF. TP-238 shows efficacy in an Alpha screen assay for both BPTF (pIC50 of 6.5) and CECR2 (pIC50 of 7.5). With a Kd of 10 nM for CECR2 and 120 nM for BPTF, isothermal titration calorimetry (ITC) reveals TP-238[1][2].
In vitro, TP-238 has on-target biochemical activity of 10-30 nM with CECR2 and 100-350 nM with BPTF. It displays potency for both CECR2 (pIC50 of 7.5) and BPTF (pIC50 of 6.5) in an Alpha screen assay. Isothermal titration calorimetry (ITC) shows TP-238 with a Kd of 10 nM for CECR2 and 120 nM for BPTF. It also inhibits BRD9 with a pIC50 of 5.9. The compound is a valuable tool for studying the biological functions of CECR2 and BPTF in cellular processes such as transcription, chromatin remodeling, and development.
ln Vivo
In vivo, TP-238 has been used in a mouse model of a developmental disorder. In this model, the compound is administered at a dose of 10 mg/kg via intraperitoneal (IP) injection once daily for 14 days. Behavioral testing is conducted 1 hour after the final injection. This study demonstrates the compound's ability to modulate CECR2 and BPTF activity in vivo. Further studies are needed to characterize its pharmacokinetic properties and its efficacy in other disease models. Its high potency and selectivity make it a valuable probe for in vivo studies.
Enzyme Assay
The non-cellular enzyme or receptor binding assay for TP-238 involves measuring its binding affinity to the bromodomains of CECR2 and BPTF. This can be performed using a time-resolved fluorescence resonance energy transfer (TR-FRET) or Alpha screen assay. In a typical Alpha screen assay, a biotinylated acetyl-lysine peptide probe is incubated with the bromodomain protein and streptavidin-coated donor beads. The binding of the protein to the peptide brings the donor and acceptor beads into proximity, generating a signal. TP-238 competes for the acetyl-lysine binding site, displacing the probe and reducing the signal. The IC50 values are determined from the dose-response curves.
Cell Assay
The in vitro cellular assay for TP-238 involves treating cells with various concentrations of the compound. The effect on CECR2 and BPTF bromodomain-dependent gene transcription is assessed by measuring the expression of target genes using quantitative RT-PCR. The compound's cellular activity can also be assessed using a reporter gene assay. In primary neuronal cultures, TP-238 is used to assess its effect on the phosphorylation status of specific proteins. The compound's selectivity is confirmed by profiling against a panel of other bromodomains and kinases. These assays are used to characterize the cellular effects of CECR2 and BPTF inhibition.
Animal Protocol
The in vivo animal experiment workflow for TP-238 involves a mouse model of a developmental disorder. The compound is administered at a dose of 10 mg/kg via intraperitoneal (IP) injection once daily for 14 days. Behavioral testing is conducted 1 hour after the final injection to assess the effect of the compound on the disorder. The compound's concentration in the brain and plasma can be measured using LC-MS/MS. Further studies are needed to determine its efficacy in other animal models and to characterize its pharmacokinetic properties.
References

[1]. Advancements in the Development of non-BET Bromodomain Chemical Probes. ChemMedChem. 2019 Feb 19;14(4):362-385.

[2]. New Inhibitors for the BPTF Bromodomain Enabled by Structural Biology and Biophysical Assay Development. Org Biomol Chem. 2020 Jun 26.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C22H30N6O3S
Molecular Weight
458.58
Exact Mass
458.21
CAS #
2415263-04-4
Related CAS #
TP-238 hydrochloride;2415263-05-5
PubChem CID
137796292
Appearance
Typically exists as solid at room temperature
LogP
2.4
tPSA
111
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
8
Rotatable Bond Count
12
Heavy Atom Count
32
Complexity
636
Defined Atom Stereocenter Count
0
SMILES
CN(C)CCCOC1=CC=C(C=C1)C2=CC(=NC(=N2)S(=O)(=O)C)NCCCN3C=CC=N3
InChi Key
MSIJJXOWLFOYIN-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H30N6O3S/c1-27(2)13-6-16-31-19-9-7-18(8-10-19)20-17-21(26-22(25-20)32(3,29)30)23-11-4-14-28-15-5-12-24-28/h5,7-10,12,15,17H,4,6,11,13-14,16H2,1-3H3,(H,23,25,26)
Chemical Name
6-[4-[3-(dimethylamino)propoxy]phenyl]-2-methylsulfonyl-N-(3-pyrazol-1-ylpropyl)pyrimidin-4-amine
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)


Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.1806 mL 10.9032 mL 21.8064 mL
5 mM 0.4361 mL 2.1806 mL 4.3613 mL
10 mM 0.2181 mL 1.0903 mL 2.1806 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration: mg/mL;

Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Contact Us